Complementary appearance of glucose and lipid metabolism in cardiac sarcoidosis.
Sarcoidosis is a non-caseating granulomatous systemic disease of unknown pathogenesis, and cardiac involvement is the most important prognostic factor. We have evaluated the value of the combined study of F-18 fluoro-2-deoxyglucose positron emission tomography and iodine-123 labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid single-photon emission tomography for the assessment of cardiac involvement of sarcoidosis, by comparing the findings with gadolinium magnetic resonance in a patient with histologically-proven cardiac sarcoidosis.
Wu
Yen-Wen
YW
Tadamura
Eiji
E
Yamamuro
Masaki
M
Kanao
Shotaro
S
Hosokawa
Ryohei
R
Kimura
Takeshi
T
Kita
Toru
T
Togashi
Kaori
K
D000368:Aged; D009202:Cardiomyopathies / Q000378:metabolism*; D005260:Female; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D050356:Lipid Metabolism; D012507:Sarcoidosis / Q000378:metabolism*
D005947:Glucose